Protein C and Protein S deficiencies are classic “thrombophilia” topics that show up on Step 1 because they connect biochemistry (vitamin K), physiology (endogenous anticoagulation), pharmacology (warfarin), and clinical medicine (DVT/PE and warfarin skin necrosis). If you can explain why warfarin can initially make patients hypercoagulable, you basically own this concept.
Big Picture: What are Protein C and Protein S?
Protein C and Protein S are vitamin K–dependent anticoagulant proteins made in the liver.
- Activated Protein C (APC) (with Protein S as a cofactor) inactivates Factors Va and VIIIa
- Net effect: decreases thrombin generation → prevents excessive clotting
High-yield one-liner
Protein C/S deficiency → loss of inhibition of Va and VIIIa → hypercoagulability → venous thrombosis (DVT/PE).
Where this fits in the coagulation cascade (Step-style)
Think of Protein C/S as “brakes” on the coagulation cascade:
- Factor V and Factor VIII are “amplifiers” (cofactors) that accelerate clot formation
- APC + Protein S shut those amplifiers off:
- APC cleaves Va
- APC cleaves VIIIa
If those brakes are missing → too much thrombin → too much fibrin → clots.
Pathophysiology: inherited vs acquired causes
Inherited Protein C/S deficiency (classic Step framing)
Usually autosomal dominant thrombophilia with variable penetrance.
- Heterozygotes: increased risk of venous thromboembolism (VTE), often in young adulthood
- Homozygous (or compound heterozygous) Protein C deficiency: severe, can present in neonates with purpura fulminans
Acquired decreases in Protein C/S (also testable)
Protein C and S levels can fall in settings like:
- Warfarin therapy (vitamin K antagonism)
- Liver disease (reduced synthesis)
- Vitamin K deficiency
- DIC/severe infection (consumption)
- Pregnancy / estrogen use (Protein S decreases physiologically in pregnancy → prothrombotic shift)
Step hint: if a question stem emphasizes “vitamin K–dependent”, you should immediately think II, VII, IX, X, C, S.
Clinical presentation (what you’ll see on exams)
Typical presentation: venous thrombosis
Protein C/S deficiency classically causes venous clots, not arterial.
Common findings:
- DVT: unilateral leg swelling, pain, warmth
- PE: pleuritic chest pain, dyspnea, tachycardia, hypoxemia
- Recurrent VTE or VTE at a young age
- VTE with a strong family history
Less common but high-yield:
- Warfarin-induced skin necrosis (Protein C deficiency is the classic association)
- Neonatal purpura fulminans (severe Protein C deficiency)
Warfarin skin necrosis (must-know mechanism)
Warfarin decreases vitamin K–dependent factors, but Protein C drops first because it has a shorter half-life than most procoagulant factors.
So early in warfarin initiation:
- Protein C falls quickly → transient hypercoagulable state
- Microthrombi form in skin vessels → painful, purpuric, necrotic skin lesions
Timing: classically 2–5 days after starting warfarin.
Step takeaway: start warfarin with a heparin bridge in high-risk patients to avoid the initial hypercoagulable period.
Diagnosis: how Step questions expect you to reason
When to suspect an inherited thrombophilia
Testing is most considered with:
- Unprovoked VTE at young age (e.g., <50)
- Recurrent VTE
- Strong family history
- Unusual sites (e.g., cerebral venous sinus, portal vein—more often mentioned with other thrombophilias but still a clue)
Lab testing (conceptual)
Protein C/S deficiency is not diagnosed with PT/PTT patterns in a simple way (those are usually normal).
Instead, diagnosis relies on:
- Protein C activity level (functional assay) and/or antigen
- Protein S level (free Protein S is most clinically relevant)
Pitfall (very testable): Do not test during acute thrombosis or while on warfarin—levels can be misleadingly low (acquired reduction).
Treatment (USMLE-relevant management)
Acute VTE management
Treat like other VTEs:
- Anticoagulation with heparin/LMWH initially
- Then transition to a long-term agent (often a DOAC in real life; Step questions may keep it general)
If using warfarin (Step classic)
- Bridge with heparin when initiating warfarin in high-risk settings
- Avoid “warfarin monotherapy” in a known Protein C deficiency patient starting treatment for an acute clot
Warfarin-induced skin necrosis management
- Stop warfarin
- Give vitamin K
- Start heparin
- Consider protein C concentrate (or FFP in some contexts)
Neonatal purpura fulminans
- Protein C replacement (protein C concentrate)
- Anticoagulation support as needed
High-yield associations & differentials (how they try to trick you)
Compare major inherited thrombophilias (Step-friendly table)
| Condition | Mechanism | Typical clot type | Key clue |
|---|---|---|---|
| Protein C deficiency | ↓ inactivation of Va, VIIIa | Venous (DVT/PE) | Warfarin skin necrosis, neonatal purpura fulminans (severe) |
| Protein S deficiency | ↓ APC cofactor | Venous | Similar to Protein C; pregnancy lowers Protein S |
| Factor V Leiden | Factor V resistant to APC cleavage | Venous | “APC resistance,” common in Caucasians |
| Prothrombin G20210A | ↑ prothrombin | Venous | Elevated prothrombin level |
| Antiphospholipid syndrome | Autoantibodies → hypercoagulability | Arterial + venous, pregnancy loss | ↑ PTT but paradoxical thrombosis |
Arterial vs venous (quick heuristic)
- Protein C/S deficiency → venous clots
- Platelet problems (e.g., atherosclerosis) → arterial clots
- APS can do both, so it’s a common distractor.
First Aid cross-references (where this lives conceptually)
In First Aid for the USMLE Step 1, you’ll see Protein C/S deficiency tied to:
- Hematology: Hemostasis & Thrombosis (inherited thrombophilias)
- Pharmacology: Anticoagulants
- Warfarin adverse effects: skin necrosis and “initial hypercoagulable state”
- Biochemistry/Path: Vitamin K–dependent factors: II, VII, IX, X, C, S
If you’re annotating FA, add:
- “Protein C drops first on warfarin (short half-life) → transient hypercoagulability”
- “Treat acute clot: heparin first, then warfarin (bridge) if used”
USMLE-style vignettes: what to listen for
Pattern 1: young patient with unprovoked DVT
- “28-year-old with DVT after a long flight” + family history → think inherited thrombophilia
If they mention skin necrosis after warfarin, Protein C is the slam dunk.
Pattern 2: warfarin complication 3 days after starting
- Painful purpuric lesions on breasts/thighs/buttocks → warfarin skin necrosis
- Ask yourself: why? → rapid fall in Protein C → microthrombosis
Pattern 3: sick neonate with rapidly progressive purpura
- Neonatal purpura fulminans → severe Protein C deficiency
Rapid review (last-minute bullets)
- Protein C (activated) + Protein S inhibit Va and VIIIa
- Deficiency → hypercoagulable → venous thrombosis
- Warfarin initially lowers Protein C faster than clotting factors → transient hypercoagulability
- Complication: warfarin-induced skin necrosis (2–5 days after initiation)
- Diagnosis: functional activity assays; avoid testing during acute clot or warfarin use
- Treatment: anticoagulate; if starting warfarin, bridge with heparin